Vaccination of rabbits with an adenovirus vector expressing the papillomavirus E2 protein leads to clearance of papillomas and infection.
Cervical cancer arises from lesions caused by infection with high-risk types of human papillomavirus (HPV). Therefore, vaccination against HPV could prevent carcinogenesis by preventing HPV infection or inducing lesion regression. HPV E2 protein is an attractive candidate for vaccine development because it is required for papilloma formation, is involved in all stages of the virus life cycle, and is expressed in all premalignant lesions as well as some cancers. This study reports vaccination against E2 protein using a rabbit model of papillomavirus infection. A recombinant adenovirus (Ad) vector expressing the E2 protein of cottontail rabbit papillomavirus (CRPV) was tested for therapeutic efficacy in CRPV-infected rabbits. Primary immunization with the Ad-E2 vaccine, compared to immunization with a control Ad vector, reduced the number of papilloma-forming sites from 17 of 45 to 4 of 45. After booster immunization, vaccinated rabbits formed no new papillomas versus an additional 23 papillomas in rabbits that received the control vector. Papillomas in the Ad-E2 vaccinees were significantly smaller than those in the control rabbits, and all four papillomas in the Ad-E2 vaccinated rabbits regressed. No CRPV DNA was detected either in the regression sites or in sites that did not form papillomas, indicating that the vaccination led to clearance of CRPV from all infected sites.
Brandsma
Janet L
JL
Section of Comparative Medicine, Yale University School of Medicine, New Haven, Connecticut 06520, USA. janet.brandsma@yale.edu
Shlyankevich
Mark
M
Zhang
Lixin
L
Slade
Martin D
MD
Goodwin
Edward C
EC
Peh
Woei
W
Deisseroth
Albert B
AB
D000256:Adenoviridae / Q000235:genetics*; D000818:Animals; D000914:Antibodies, Viral / Q000097:blood; D012777:Cottontail rabbit papillomavirus / Q000235:genetics / Q000276:immunology* / Q000302:isolation & purification; D005260:Female; D005822:Genetic Vectors; D010212:Papilloma / Q000517:prevention & control* / Q000821:virology; D030361:Papillomavirus Infections / Q000517:prevention & control* / Q000821:virology; D011817:Rabbits; D014157:Transcription Factors / Q000008:administration & dosage* / Q000235:genetics / Q000276:immunology / Q000378:metabolism; D014611:Vaccination; D019444:Vaccines, DNA / Q000008:administration & dosage / Q000276:immunology; D014764:Viral Proteins / Q000008:administration & dosage* / Q000235:genetics / Q000276:immunology / Q000378:metabolism; D014765:Viral Vaccines / Q000008:administration & dosage* / Q000276:immunology
D000914:Antibodies, Viral; C422983:E2 protein, Cottontail rabbit papillomavirus; D014157:Transcription Factors; D019444:Vaccines, DNA; D014764:Viral Proteins; D014765:Viral Vaccines